Operating Lease, Right-of-Use Asset of Oruka Therapeutics, Inc. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Oruka Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • Oruka Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $1,969,000, a 110% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Oruka Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,969,000 +$1,031,000 +110% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $2,076,000 +$2,068,000 +25850% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $814,000 +$797,000 +4688% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $876,000 +$629,000 +255% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 $938,000 +$671,000 +251% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 $8,000 -$285,000 -97% 30 Jun 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 $17,000 -$301,000 -95% 31 Mar 2024 10-Q 25 Apr 2024 2024 Q1
Q4 2023 $247,000 -$96,000 -28% 31 Dec 2023 10-Q 01 Aug 2024 2024 Q2
Q3 2023 $267,000 -$100,000 -27% 30 Sep 2023 10-Q 18 Oct 2023 2023 Q3
Q2 2023 $293,000 -$98,000 -25% 30 Jun 2023 10-Q 21 Jul 2023 2023 Q1
Q1 2023 $318,000 -$96,000 -23% 31 Mar 2023 10-Q 24 Apr 2023 2023 Q1
Q4 2022 $343,000 -$94,000 -22% 31 Dec 2022 10-K 01 Feb 2024 2023 FY
Q3 2022 $367,000 -$93,000 -20% 30 Sep 2022 10-Q 28 Oct 2022 2022 Q3
Q2 2022 $391,000 -$91,000 -19% 30 Jun 2022 10-Q 02 Aug 2022 2022 Q2
Q1 2022 $414,000 $0 0% 31 Mar 2022 10-Q 02 May 2022 2022 Q1
Q4 2021 $437,000 +$9,000 +2.1% 31 Dec 2021 10-K 24 Feb 2023 2022 FY
Q3 2021 $460,000 30 Sep 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 $482,000 +$458,000 +1908% 30 Jun 2021 10-Q 04 Aug 2021 2021 Q2
Q1 2021 $414,000 +$365,000 +745% 31 Mar 2021 10-Q 11 May 2021 2021 Q1
Q4 2020 $428,000 +$406,000 +1845% 31 Dec 2020 10-K 14 Mar 2022 2021 FY
Q2 2020 $24,000 -$4,000 -14% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 $49,000 +$5,000 +11% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $22,000 31 Dec 2019 10-K 18 Mar 2021 2020 FY
Q3 2019 $11,000 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 $28,000 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 $44,000 31 Mar 2019 10-Q 08 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.